Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma
Data Presented at International Melanoma Conference in BerlinResults Follow Decision by Company to Continue Phase 3 AGENDA Trialfor Overall SurvivalBERKELEY HEIGHTS, NJ – November 20, 2009 – GentaIncorporated (OTCBB: GETA.OB)…
November 23rd, 2009
Posted in
Drug